Latest News about ABCL
Recent news which mentions ABCL
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
From Benzinga
From Benzinga
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
December 13, 2022
From Benzinga
Pinterest, Oracle And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
December 13, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
From Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
November 11, 2022
From Benzinga
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session
November 10, 2022
From Benzinga
Why Cano Health Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket
November 10, 2022
From Benzinga
Coupang, Rivian Automotive And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 10, 2022
From Benzinga
Why Array Technologies Shares Are Trading Sharply Higher; Here Are 28 Stocks Moving Premarket
November 09, 2022
From Benzinga
AbCellera Biologics Inc. (ABCL) Q3 2022 Earnings Call Transcript
November 08, 2022
Tickers
ABCL
From Motley Fool
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
September 02, 2022
From InvestorPlace
From Benzinga
From Benzinga
Why AbCellera Biologics Rallied as Much as 24% on Wednesday
August 10, 2022
Tickers
ABCL
From Motley Fool
Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday's Mid-Day Session
August 10, 2022
From Benzinga
From Benzinga
AbCellera Biologics Inc. (ABCL) Q2 2022 Earnings Call Transcript
August 10, 2022
Tickers
ABCL
From Motley Fool
From Benzinga
Why AbCellera Biologics Is 10% Lower Today
May 11, 2022
From Motley Fool
Tickers
ABCL
From Motley Fool
3 Biotech Stocks Under $10 to Add to Your Buy List
April 26, 2022
From InvestorPlace
AbCellera Biologics Inc. (ABCL) Q4 2021 Earnings Call Transcript
February 25, 2022
Tickers
ABCL
From Motley Fool
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
From Benzinga
Is It Time to Buy the Nasdaq's 11 Worst-Performing Stocks of 2021?
December 08, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.